Cargando…

Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis

Cancer cells can exhibit resistance to different anticancer drugs by acquiring enhanced anti-apoptotic potential, improved DNA injury resistance, diminished enzymatic inactivation, and enhanced permeability, allowing for cell survival. However, the genetic mechanisms for these effects are unknown. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Jin Hong, Choi, Kyung Hwa, Kim, Soo Young, Park, Cheong Soo, Kim, Seok-Mo, Park, Ki Cheong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589077/ https://www.ncbi.nlm.nih.gov/pubmed/33050525 http://dx.doi.org/10.3390/ijms21207469

Ejemplares similares

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()
por: Lee, Yong Sang, et al.
Publicado: (2018)

Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
por: Kim, Seok-Mo, et al.
Publicado: (2020)

Induction of Apoptosis and Inhibition of Epithelial Mesenchymal Transition by α-Mangostin in MG-63 Cell Lines
por: Park, Sung-Jin, et al.
Publicado: (2018)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma
por: Lim, Jin Hong, et al.
Publicado: (2022)

PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
por: Park, Ki Cheong, et al.
Publicado: (2023)

Non-toxic antimicrobials that evade drug resistance
por: Davis, Stephen A., et al.
Publicado: (2015)

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
por: Park, Hun Ho, et al.
Publicado: (2021)

Multiphysics and Multiscale Analysis for Chemotherapeutic Drug
por: Zhang, Linan, et al.
Publicado: (2015)

Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells
por: Chen, Hsin-Pao, et al.
Publicado: (2017)

WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
por: Martin-Orozco, Elena, et al.
Publicado: (2019)

Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug
por: Patel, Nibedita, et al.
Publicado: (2018)

ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis
por: Lee, Tae-Jin, et al.
Publicado: (2021)

Peroxiredoxin-6 regulates p38-mediated epithelial–mesenchymal transition in HCT116 colon cancer cells
por: Chae, Unbin, et al.
Publicado: (2021)

Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence
por: Park, Cheong Soo, et al.
Publicado: (2013)

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer
por: Kim, Seok-Mo, et al.
Publicado: (2015)

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate
por: Lim, Ka Young, et al.
Publicado: (2022)

RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells
por: Cho, Hee Jun, et al.
Publicado: (2014)

Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress
por: Shah, Parag P., et al.
Publicado: (2017)

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]
por: Park, Ki Cheong, et al.
Publicado: (2017)

Predicting factors for success of vaginal delivery in preterm induction with prostaglandin E(2)
por: Kim, Yoo Min, et al.
Publicado: (2017)

Bortezomib inhibits proliferation, migration, and TGF-β1–induced epithelial–mesenchymal transition of RPE cells
por: Moon, Kun, et al.
Publicado: (2017)

Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy
por: Kim, Bup-Woo, et al.
Publicado: (2017)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Treatment of Human Placental Choriocarcinoma Cells with Formaldehyde and Benzene Induced Growth and Epithelial Mesenchymal Transition via Induction of an Antioxidant Effect
por: Lee, Hae-Miru, et al.
Publicado: (2017)

Apolipoprotein A1 Inhibits TGF-β1–Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial Cells
por: Baek, Ae Rin, et al.
Publicado: (2016)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

Blood culture contamination in hospitalized pediatric patients: a single institution experience
por: Min, Hyewon, et al.
Publicado: (2014)

Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies
por: de Groot, Ruben Cornelis Anthonie, et al.
Publicado: (2022)

ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
por: Guo, Cao, et al.
Publicado: (2017)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis
por: Wang, Fangqing, et al.
Publicado: (2021)

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019)

Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
por: Kim, Soo Young, et al.
Publicado: (2020)

Predicting chemotherapeutic drug combinations through gene network profiling
por: Nguyen, Thi Thuy Trang, et al.
Publicado: (2016)

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

Solitary lateral neck node metastasis in papillary thyroid carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2014)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8fbu6kuu141ig1hjm1onr63q63